What is the price target for CTSO stock?
8 analysts have analysed CTSO and the average price target is 5.36 USD. This implies a price increase of 711.36% is expected in the next year compared to the current price of 0.66.
CYTOSORBENTS CORP (CTSO) Forecast, Price Target & Analyst Ratings
NASDAQ:CTSO • US23283X2062
Current stock price
0.66 USD
+0.05 (+8.2%)
At close:
0.64 USD
-0.02 (-3.03%)
After Hours:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CYTOSORBENTS CORP (CTSO).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- May 5, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$0.06
- Revenue Estimate
- 9.55M
Price Target Details & History
Consensus Price Target and Range
Mean target
$5.36
Upside
+ 711.36%
From current price of $0.66 to mean target of $5.36, Based on 8 analyst forecasts
Low
$0.76
Median
$5.10
High
$10.50
Price Target Revisions
1 Month
0.00%
3 Months
-2.33%
Price Target Summary
8 Wall Street analysts provided a forecast for the next 12 months for CTSO. The average price target is 5.36 USD. This implies a price increase of 711.36% is expected in the next year compared to the current price of 0.66.
The average price target has been revised downward by 2.33% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
80.00%
CTSO was analyzed by 8 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about CTSO.
In the previous month the buy percentage consensus was at a similar level.
CTSO was analyzed by 8 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-26 | D. Boral Capital | Maintains | Buy -> Buy |
| 2026-01-12 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-12-16 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-11-14 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-11-14 | HC Wainwright & Co. | Maintains | Neutral -> Neutral |
| 2025-09-16 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-08-20 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-08-08 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-07-21 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-06-25 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-05-15 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-05-15 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2025-05-02 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-04-03 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2025-04-01 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-02-25 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-01-13 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-01-03 | D. Boral Capital | Maintains | Buy -> Buy |
| 2024-11-12 | D. Boral Capital | Maintains | Buy -> Buy |
| 2024-11-11 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2024-11-08 | EF Hutton | Maintains | Buy -> Buy |
| 2024-11-04 | EF Hutton | Maintains | Buy -> Buy |
| 2024-10-22 | EF Hutton | Maintains | Buy -> Buy |
| 2024-10-01 | EF Hutton | Maintains | Buy -> Buy |
| 2024-08-14 | EF Hutton | Maintains | Buy -> Buy |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- May 5, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$0.06
- Revenue Estimate
- 9.55M
- Revenue Q2Q
- 9.43%
- EPS Q2Q
- -180.50%
- Number of Analysts
- 4
Next Earnings Revisions
Revenue (1 Month)
0.00%
Revenue (3 Months)
-0.30%
EPS (1 Month)
0.00%
EPS (3 Months)
-25.00%
Next Earnings Summary
CTSO is expected to report earnings on 5/5/2026. The consensus EPS estimate for the next earnings is -0.06 USD and the consensus revenue estimate is 9.55M USD.
The next earnings revenue estimate has been revised downward by 0.3% in the past 3 months.
Full Analyst Estimates 2026 - 2032
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 31.085M -10.39% | 35.595M 14.51% | 37.063M 4.13% | 40.897M 10.34% | 50.063M 22.41% | 58.064M 15.98% | 130.45M 124.67% | 277.47M 112.70% | 343.33M 23.74% | 452.77M 31.88% | |
| EBITDA YoY % growth | -29.831M 2.64% | -14.882M 50.11% | N/A 23.32% | -1.255M 89.01% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -31.293M 0.72% | -16.452M 47.43% | -14.239M 13.45% | -6.987M 50.93% | -3.98M 43.04% | 25.447M 739.37% | 59.878M 135.30% | 174.91M 192.11% | 224.48M 28.34% | 306.69M 36.62% | |
| Operating Margin | -100.67% | -46.22% | -38.42% | -17.08% | -7.95% | 43.83% | 45.90% | 63.04% | 65.38% | 67.74% | |
| EPS YoY % growth | -0.65 14.47% | -0.38 41.54% | -0.13 65.79% | -0.17 -33.38% | -0.06 64.71% | 0.02 125.00% | N/A | N/A | N/A | N/A |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -0.06 -180.50% | -0.05 -270.00% | -0.04 18.40% | -0.05 43.33% |
| Revenue Q2Q % growth | 9.55M 9.43% | 10.937M 13.73% | 10.68M 12.60% | 10.483M 13.53% |
| EBITDA Q2Q % growth | -2.755M 21.70% | -26.52K 99.07% | -126.48K 91.71% | -58.14K |
| EBIT Q2Q % growth | -3.133M 19.39% | -395.76K 89.05% | -486.54K 81.72% | -409.02K 89.90% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
28.42%
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
14.99%
Revenue Next 5 Year
48.68%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
CYTOSORBENTS CORP / CTSO Forecast FAQ
When does CYTOSORBENTS CORP (CTSO) report earnings?
CYTOSORBENTS CORP (CTSO) will report earnings on 2026-05-05, after the market close.
Can you provide the consensus estimates for CYTOSORBENTS CORP next earnings?
The consensus EPS estimate for the next earnings of CYTOSORBENTS CORP (CTSO) is -0.06 USD and the consensus revenue estimate is 9.55M USD.
What is the expected long term growth rate for CTSO stock?
The expected long term growth rate for CYTOSORBENTS CORP (CTSO) is 14.99%.